Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis B

NCT02881008 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Entecavir
DRUG: Myrcludex B

Sponsor

Hepatera Ltd.